Abstract:The conversion of proteins from their native state into well-organized fibrillar aggregates, whether inside cells or in the extracellular space of connective tissue, leads to the pathogenesis of several human diseases that include neurodegenerative diseases as well as non-neuropathic conditions, such as systemic amyloidosis. Neurodegenerative diseases including Alzheimer's disease (AD) Parkinson's disease, and Huntington's disease are marked by personality changes, memory loss (dementia), cognitive changes, blurred vision, insomnia, and loss of motor control. Despite substantial advances, these disorders are usually fatal or lead- to serious debilitation and dramatic worsening of the quality of life. As a result, there is a widely appreciated need to further elucidate the pathogenesis of these diseases and to develop effective therapies. Significant progress in elucidating molecular mechanisms that trigger the aggregation and the pathogenicity of proteins has enabled the design of novel and potentially powerful treatments. Nevertheless, little is known of the critical interactions in the complex in-vivo milieu which determines where and when protein deposition occurs in individual patients. Moreover, understanding of which molecular species are responsible for pathogenesis is far from complete.14-3-3 proteins are small, conserved scaffolding molecules that are expressed in all eukaryotes. They modulate the function of other proteins, primarily in a phosphorylation-dependent manner. They are abundantly expressed in the brain and are often thought to be involved in age-related neurodegenerative diseases. To date, several hundreds of 14-3-3 binding partners have been identified. This diverse group includes protein kinases, phosphatases, receptors, transcription factors, structural and cytoskeletal proteins, as well as small G-proteins and their regulators. Consequently, 14-3-3 proteins could be promising targets for therapeutic intervention. Previous studies on invertebrates have demonstrated the importance of these proteins for regulation of synaptic function, learning and memory. Nevertheless, the exact roles of 14-3-3 proteins in neurodegenerative diseases are still unclear. The present collection of articles brings together original research, reviews, and perspectives in the biology of 14-3-3 proteins and their possible relevance for therapy of neurodegenerative disease. An article by Obsilova and Obsil (2024) describes the molecular mechanisms through which 14-3-3 proteins regulate their binding partners. These mechanisms fall into three categories: 1) direct conformational modulation of the bound partner; 2) physical occlusion of sequence-specific or structural features on the surface of the target protein; and 3) scaffolding, which facilitates protein-protein interactions (Obsilova and Obsil, 2024).Although most binding partners of 14-3-3 proteins contain phosphorylated binding motifs, these proteins can also bind to non-phosphorylated motifs with high affinity. One example of phosphorylation-independent interaction is with exoenzyme S (ExoS), a bacterial ADP-ribosyltransferase toxin of Pseudomonas aeruginosa. This interaction is essential for toxin function. Structural studies on the complex between 14-3-3ζ and the ExoS peptide, identified as an amphipathic motif, revealed that the ExoS peptide binds to 14-3-3 mainly through hydrophobic contacts (Ottmann et al., 2007a). Another well-characterized peptide, the R18 peptide, derived from a phage display library, binds 14-3-3 proteins with high affinity through an amphipathic motif (Wang et al., 1999). 14-3-3 proteins modulate the activity of many enzymes including arylalkylamine N-acetyltransferase, tyrosine hydroxylase, tryptophan hydroxylase, yeast neutral trehalase, apoptosis signal-regulating kinases, protein kinases B-RAF and C-RAF, leucine-rich repeat protein kinase-2 (LRRK2), protein kinase C (PKC), calcium/calmodulin-dependent protein kinase kinases, death-associated protein kinase 2, phosphatidylinositol-4-kinase-III, protein phosphatase CDC25C, and E3 ligase neural precursor cell expressed developmentally down-regulated 4 ligase. Interestingly,14-3-3 protein binding motifs, are often located near a nuclear localization sequence (NLS) or nuclear export sequence (NES) and can thereby modulate the subcellular localization of its target (Muslin and Xing, 2000)). A well-known example is Forkhead box O transcription factors (FOXO), which are crucial for cell survival, DNA damage repair, and stress resistance (Gui and Burgering, 2021). Other examples are Class II histone deacetylases (HDAC4 and HDAC5), whose subcellular localization is controlled in a phosphorylation-dependent and 14-3-3 dependent manner through two 14-3-3 binding motifs: a NLS located between these two motifs, and a NES at the C-terminus, which is inactive in unphosphorylated HDACs. Obsilova and Obsil (2024) and o -Abstract Truncated-

Interaction of 14-3-3 with a Nonphosphorylated Protein Ligand, Exoenzyme S of Pseudomonas Aeruginosa.

Residues of 14-3-3 Zeta Required for Activation of Exoenzyme S of Pseudomonas Aeruginosa.

Raf-1 Kinase and Exoenzyme S Interact with 14-3-3ζ Through a Common Site Involving Lysine 49*

Editorial: 14-3-3 proteins: possible importance in neurodegenerative diseases

Phosphorylated Physarum Polycephalum 14-3-3 Modulates the Distribution of the P. Polycephalum SR-like Protein Through the Arginine/serine-rich Domain

Isolation of high-affinity peptide antagonists of 14-3-3 proteins by phage display.

NMR Spectroscopy of 14-3-3ζ Reveals a Flexible C-terminal Extension: Differentiation of the Chaperone and Phosphoserine-Binding Activities of 14-3-3Ζ.

Negative Charges, Not Necessary Phosphorylation, are Required for Ligand Recognition by 14-3-3 Proteins

Inhibition of Phosphatidylinositol 3-Kinase Activity by Association with 14-3-3 Proteins in T Cells.

14-3-3 Proteins: a Window for a Deeper Understanding of Fungal Metabolism and Development

The Interaction Between ADAM 22 and 14-3-3zeta: Regulation of Cell Adhesion and Spreading.

Identification Of 14-3-3 Proteins Phosphopeptide-Binding Specificity Using An Affinity-Based Computational Approach

Revealing the binding modes and the unbinding of 14-3-3σ proteins and inhibitors by computational methods

14-3-3 binding creates a memory of kinase action by stabilizing the modified state of phospholamban

Molecular interaction mechanism of a 14-3-3 protein with a phosphorylated peptide elucidated by enhanced conformational sampling

14-3-3Ζ Interacts with Stat3 and Regulates Its Constitutive Activation in Multiple Myeloma Cells.

How phosphorylation of peptides affects their interaction with 14-3-3η domains

Mutations in the Hydrophobic Surface of an Amphipathic Groove of 14-3-3ζ Disrupt Its Interaction with Raf-1 Kinase

The Chaperone Protein 14-3-3 Interacts with 3BP2/SH3BP2 and Regulates Its Adapter Function

14–3-3ε: a protein with complex physiology function but promising therapeutic potential in cancer

Identification of 14-3-3epsilon Substrates from Embryonic Murine Brain.